👀 Check out their paper https://t.co/CiWQewYt5j
914 followers
216 followers
A new collaboration paper involving our group further exploring the activity of our L1 ORF2p inhibitor SPV122.
1,567 followers
Our SPV122, an inhibitor of L1 ORF2p, strongly inhibits BRAF-mutant melanoma cell growth, and delays the emergence of resistance. Happy to collaborate on this work, finally published in Cell Communication and Signaling @BioMedCentral https://t.co/XwiXpGGJJ
353 followers
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization https://t.co/6CBkUpv8T1